free webinar on august 16 about drug-resistant tuberculosis
FREE WEBINAR: Implementing a Bedaquiline-Based, Injectable-Free Regimen for Drug-Resistant Tuberculosis August 16, 2018 10 am EDT / 4 pm South Africa / 5 pm KenyaREGISTER HERE
We invite you to join a critical discussion on August 16, 2018 at 10 am New York / 4pm South Africa / 5pm Kenya as TAG, TB CAB, and DR-TB STAT host a webinar on Implementing a bedaquiline-based, injectable-free regimen for drug-resistant tuberculosis (DR-TB) in light of the new WHO policy brief on DR-TB regimens.
Dr. Nobert Ndjeka from the National Department of Health in South Africa will be talking about the South African experience as the first country to roll out this unique and less toxic regimen and how the South Africa regimen differs from the new WHO policy brief on DR-TB regimens (including advantages and disadvantages).
Eunice Omesa, the Section Head for Monitoring, Evaluation & Research from the Ministry of Health in Kenya will be talking about practical considerations countries have in order to implement a bedaquiline-based, injectable-free regimen bearing in mind the new WHO policy brief on DR-TB regimens.
We’ll also include perspectives from a survivor of drug-resistant TB, and other members of civil society. TB survivor and TB PROOF management committee member Phumeza Tisile will share her experience with injectable drug-induced hearing loss and recommendations for national programs. The discussion will be moderated by Marcus Low, Spotlight editor and technical co-lead of the Global TB Community Advisory Board. Closed captioning will be available at this link: http://www.streamtext.net/player?event=TAG. Please rearrange your screens to view the live transcription and the presentation.